SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Dec-21 8:41 PM View: | Spyre Therapeutics, Inc. (SYRE) | 13-Dec-21 | Purchase | 14,685 | $3.65 | $53,600.20 | 11% 135.31K to 150.0K | |
13-Dec-21 8:41 PM View: | Spyre Therapeutics, Inc. (SYRE) | 10-Dec-21 | Purchase | 13,516 | $3.65 | $49,333.40 | 11% 121.8K to 135.31K | |
13-Dec-21 8:41 PM View: | Spyre Therapeutics, Inc. (SYRE) | 09-Dec-21 | Private Purchase | 121,799 | $3.67 | $446,759.00 | 100% 0 to 121.8K | |
23-Apr-18 4:16 PM View: | Surface Oncology, Inc. (SURF) | 23-Apr-18 | Conversion Duplicate | 3,181,820 | -- | -- | 100% 0 to 3.18M | |
23-Apr-18 4:16 PM View: | Surface Oncology, Inc. (SURF) | 23-Apr-18 | Purchase | 266,000 | $15.00 | $3,990,000.00 | 8% 3.18M to 3.45M | |
07-Jul-17 7:18 PM View: | Aileron Therapeutics, Inc. (ALRN) | 05-Jul-17 | Conversion Duplicate | 844,987 | -- | -- | 100% 0 to 844.99K | |
07-Jul-17 7:18 PM View: | Aileron Therapeutics, Inc. (ALRN) | 05-Jul-17 | Purchase Duplicate | 250,000 | $15.00 | $3,750,000.00 | 30% 844.99K to 1.09M | |
16-Aug-16 6:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 16-Aug-16 | Conversion Duplicate | 1,516,150 | -- | -- | 100% 0 to 1.52M | |
16-Aug-16 6:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 16-Aug-16 | Purchase Duplicate | 583,333 | $12.00 | $7,000,000.00 | 38% 1.52M to 2.1M |